Search Results - Dorian Forte
- Showing 1 - 12 results of 12
-
1
-
2
-
3
-
4
Circulating Calreticulin Is Increased in Myelofibrosis: Correlation with Interleukin-6 Plasma Levels, Bone Marrow Fibrosis, and Splenomegaly by Daria Sollazzo, Dorian Forte, Nicola Polverelli, Margherita Perricone, Marco Romano, Simona Luatti, Nicola Vianelli, Michele Cavo, Francesca Palandri, Lucia Catani
Published in Mediators of Inflammation (2016-01-01)Get full text
Article -
5
Mutations in JAK2 and Calreticulin genes are associated with specific alterations of the immune system in myelofibrosis by Marco Romano, Daria Sollazzo, Sara Trabanelli, Martina Barone, Nicola Polverelli, Margherita Perricone, Dorian Forte, Simona Luatti, Michele Cavo, Nicola Vianelli, Camilla Jandus, Francesca Palandri, Lucia Catani
Published in OncoImmunology (2017-10-01)Get full text
Article -
6
Mobilized Peripheral Blood versus Cord Blood: Insight into the Distinct Role of Proinflammatory Cytokines on Survival, Clonogenic Ability, and Migration of CD34+ Cells by Dorian Forte, Daria Sollazzo, Martina Barone, Marisole Allegri, Angela di Martella Orsi, Marco Romano, Barbara Sinigaglia, Giuseppe Auteri, Nicola Vianelli, Michele Cavo, Francesca Palandri, Lucia Catani
Published in Mediators of Inflammation (2018-01-01)Get full text
Article -
7
PB1865: NPM1-MUT MONITORING DURING GILTERITINIB TREATMENT IDENTIFIES DIFFERENT DYNAMICAL PATTERNS IN RESPONSIVE PATIENTS by Chiara Sartor, Emanuela Ottaviani, Jacopo Nanni, Raffaele Ciruolo, Gianluca Cristiano, Letizia Zannoni, Federico Zingarelli, Lorenza Bandini, Agnese Patuelli, Claudia Venturi, Valentina Robustellu, Dorian Forte, Michele Cavo, Antonio Curti, Cristina Papayannidis
Published in HemaSphere (2023-08-01)Get full text
Article -
8
Ex vivo characterization of acute myeloid leukemia patients undergoing hypomethylating agents and venetoclax regimen reveals a venetoclax-specific effect on non-suppressive regulat... by Giulia Corradi, Giulia Corradi, Dorian Forte, Gianluca Cristiano, Andrea Polimeno, Marilena Ciciarello, Marilena Ciciarello, Marilena Ciciarello, Valentina Salvestrini, Lorenza Bandini, Valentina Robustelli, Emanuela Ottaviani, Michele Cavo, Michele Cavo, Darina Ocadlikova, Antonio Curti
Published in Frontiers in Immunology (2024-05-01)Get full text
Article -
9
Corrigendum: Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia Cells by Valentina Salvestrini, Marilena Ciciarello, Valentina Pensato, Giorgia Simonetti, Maria Antonella Laginestra, Maria Antonella Laginestra, Samantha Bruno, Martina Pazzaglia, Elena De Marchi, Dorian Forte, Stefania Orecchioni, Giovanni Martinelli, Francesco Bertolini, Simon Méndez-Ferrer, Simon Méndez-Ferrer, Simon Méndez-Ferrer, Elena Adinolfi, Francesco Di Virgilio, Michele Cavo, Antonio Curti
Published in Frontiers in Oncology (2021-04-01)Get full text
Article -
10
Parallel single-cell metabolic analysis and extracellular vesicle profiling reveal vulnerabilities with prognostic significance in acute myeloid leukemia by Dorian Forte, Roberto Maria Pellegrino, Paolo Falvo, Paulina Garcia-Gonzalez, Husam B. R. Alabed, Filippo Maltoni, Davide Lombardi, Samantha Bruno, Martina Barone, Federico Pasini, Francesco Fabbri, Ivan Vannini, Benedetta Donati, Gianluca Cristiano, Chiara Sartor, Simona Ronzoni, Alessia Ciarrocchi, Sandra Buratta, Lorena Urbanelli, Carla Emiliani, Simona Soverini, Lucia Catani, Francesco Bertolini, Rafael José Argüello, Michele Cavo, Antonio Curti
Published in Nature Communications (2024-12-01)Get full text
Article -
11
Circulating extracellular particles from severe COVID-19 patients show altered profiling and innate lymphoid cell-modulating ability by Dorian Forte, Roberto Maria Pellegrino, Sara Trabanelli, Sara Trabanelli, Tommaso Tonetti, Tommaso Tonetti, Francesca Ricci, Mara Cenerenti, Mara Cenerenti, Giorgia Comai, Pierluigi Tazzari, Tiziana Lazzarotto, Tiziana Lazzarotto, Sandra Buratta, Lorena Urbanelli, Ghazal Narimanfar, Husam B. R. Alabed, Cristina Mecucci, Gaetano La Manna, Carla Emiliani, Camilla Jandus, Camilla Jandus, Vito Marco Ranieri, Vito Marco Ranieri, Michele Cavo, Michele Cavo, Lucia Catani, Lucia Catani, Francesca Palandri
Published in Frontiers in Immunology (2023-05-01)Get full text
Article -
12
Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysis by Zijian Fang, Giuditta Corbizi Fattori, Thomas McKerrell, Rebecca H. Boucher, Aimee Jackson, Rachel S. Fletcher, Dorian Forte, Jose-Ezequiel Martin, Sonia Fox, James Roberts, Rachel Glover, Erica Harris, Hannah R. Bridges, Luigi Grassi, Alba Rodriguez-Meira, Adam J. Mead, Steven Knapper, Joanne Ewing, Nauman M. Butt, Manish Jain, Sebastian Francis, Fiona J. Clark, Jason Coppell, Mary F. McMullin, Frances Wadelin, Srinivasan Narayanan, Dragana Milojkovic, Mark W. Drummond, Mallika Sekhar, Hesham ElDaly, Judy Hirst, Maike Paramor, E. Joanna Baxter, Anna L. Godfrey, Claire N. Harrison, Simón Méndez-Ferrer
Published in Nature Communications (2023-11-01)Get full text
Article
